Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-NS-23-014

Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed)

Closed on September 19, 2022.

Posted
July 8, 2022
Close date
September 19, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,250,030 in first-year total cost, median $2,250,030.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-O (21)]1

Most frequent institutions

  1. TRANSLATIONAL GENOMICS RESEARCH INST1
Competing awards under RFA-NS-23-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023A Large-scale Extracellular Vesicle RNA-seq Resource for Parkinsons Disease1R24NS132738-01CRAIG, DAVID WDONG, XIANJUNEITAN, EREZTRANSLATIONAL GENOMICS RESEARCH INST, AZ$2,250,030ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-NS-23-014: Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) | ScienceDex | ConductScience